Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...
ScienceAlert on MSN6 天
New Drug May Prevent Cognitive Decline in Parkinson's Disease
A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.
Intra-Cellular Therapies: Parkinson's Disease Drug Expansion Could Be The Next Huge Move
Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.
Science Daily3 天
Parkinson's Research News
which could lead to treatments for the cognitive symptoms of Parkinson's disease ... New Drug Targets for Alzheimer's Identified from Cerebrospinal Fluid Nov. 14, 2024 — Researchers have linked ...
AbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpoint
The company plans to submit a new drug application for tavapadon to the US Food and Drug Administration next year.
News Medical on MSN1 天
£1M funding boost for new project to trial Parkinson’s treatments on digital twin brain
People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...
globes.co.il2 天
"The best Parkinson's medication will be Israeli, and hybrid"
"The best medication for Parkinson's will come from Israel. It will be a hybrid medication, and the world's best hybrid ...
STAT1 天
Do GLP-1s work for Parkinson’s? A health tech startup pitches pharma on quick answers
Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...